WERNER ROBERT F. 4

Accession 0001214659-26-001239

CIK 0001581280other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 4:05 PM ET

Size

7.1 KB

Accession

0001214659-26-001239

AI-generated summary of this filing

Updated Feb 5, 2026

Twist Bioscience (TWST) Chief Accounting Officer Robert F. Werner Sells Shares

What Happened

Robert F. Werner, Chief Accounting Officer of Twist Bioscience (TWST), reported sales of a total of 7,175 shares in early February 2026, generating roughly $327,687.
Transactions: 175 shares sold on 2026-02-03 at $46.58 each ($8,151) and 7,000 shares sold on 2026-02-04 at $45.65 each ($319,536). Both sales are reported as disposals (code S).

Key Details

Dates and prices:
- 2026-02-03: 175 shares @ $46.58 = $8,151.
- 2026-02-04: 7,000 shares @ $45.65 = $319,536.
- Footnote F2: weighted average sales price and range noted; sales prices ranged $45.61–$45.78; detailed per-price breakdown available upon request.
Reason/footnote: Footnote F1 states these sales represent shares sold to satisfy tax withholding obligations tied to RSU vesting ("sell-to-cover") and are not discretionary trades by the reporting person.
Shares owned after the transactions: not specified in the provided excerpt of the filing.
Timeliness: Form 4 was filed on 2026-02-05; based on the report dates (Feb 3–4) the filing appears timely.

Context

These reported sales were primarily sell-to-cover transactions for tax withholding related to equity vesting, which are routine and do not necessarily reflect the insider’s view on the company. No purchases or option exercises were reported in this filing.

Form 4

Period: 2026-02-03

Chief Accounting Officer

Transactions

Footnotes (2)

[F1]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.
[F2]Represents the weighted average sales price per share. The shares sold at prices ranging from $45.61 to $45.78 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Signature

/s/ Kendra Fox, as Attorney-in-Fact for Robert F. Werner|2026-02-05

1 file

Twist Bioscience Corp

CIK 0001581280

Entity typeother